about
Characterization of clonogenic multiple myeloma cellsCancer stem cells: relevance to clinical transplantationCyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapySustained proliferation in cancer: Mechanisms and novel therapeutic targetsCombination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitorsCancer stem cells in solid tumors: elusive or illusive?Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcomaImplications of heterogeneity in multiple myeloma.Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence patternPhenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesProgress in myeloma stem cellsClonogenic assay of gastric adenocarcinoma stem cells--clonogenic assay, stomach cancerImproved optical detection of colony enlargement and drug cytotoxicity in primary soft agar cultures of human solid tumour cellsImproved culture conditions for clonogenic growth of primary human breast tumours.Clonogenic growth and hormone sensitivity of benign and malignant breast tissues.Direct "wet" staining of tumour or haematopoietic colonies in agar culture.Human tumour karyology: marked analytic improvement by short-term agar culture.Colony formation by normal and malignant human B-lymphocytesHuman tumour clonogenicity in agar is improved by cell-free ascites.Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?Targeting the perpetrator: breast cancer stem cell therapeuticsTransformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftmentIdentification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1In vitro evaluation of chemotherapeutic agents.Chemosensitivity testing: a critical review.Cancer stem cells in multiple myeloma.Functional features of cancer stem cells in melanoma cell lines.Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis.Origin and maintenance of the intestinal cancer stem cell.Head and neck cancer stem cells.Human skin cancer stem cells: a tale of mice and men.Function of oncogenes in cancer development: a changing paradigm.Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.Cancer stem cells of differentiated B-cell malignancies: models and consequences.Fact or fiction--identifying the elusive multiple myeloma stem cell.
P2860
Q24610291-EB8BE64A-162C-45E1-8791-E773455707FCQ27008959-248D12A8-FB5E-4541-9A26-7769AD4C6734Q28073252-D935D0F1-8BE2-4EF5-90C1-2D797A1C97E8Q28396388-3FF0EF94-C3CB-4738-933B-C91EB7550034Q28537997-D1A5F531-431F-467A-8BDC-BAD0028AB6F5Q33349066-2E790BE7-07C7-4A8F-A5DC-63E0AC1E0155Q33737393-23D57507-F89E-4B49-935C-4616883391E3Q33914824-68DB4C26-06CD-4468-B715-8AD4C2E83814Q34194873-440F605C-ABC3-4464-9E1F-CED90DC65A13Q34383712-E3CA3BD9-224D-4251-8589-BD97B94C0DF2Q34556074-2C19CF8D-5605-4F0F-8E27-66424CB12302Q34571611-12DC3013-6923-4460-94BF-50100708E9EBQ35128148-7599D46B-8DBC-491B-8809-AA40AA509D11Q35824980-3BB6C1E3-C5CD-4B5D-B5A7-2E941877FA35Q35948334-AB473399-A82A-441E-A775-A65AFDB39EFAQ35991344-971FA070-5F54-465E-B1F5-2E6710782E82Q35991750-A7CD29D1-D4F8-41DE-8AB7-256E4E65CE1FQ36028459-D9F2C0FA-980D-4CB8-9994-0F372D5EA6D0Q36043217-A5899396-07E7-4370-852B-1D81487207BAQ36044053-E77614BD-1C61-4458-9CDC-2F6D2FB010B5Q36044301-345C3CD1-9405-45CD-B35C-938B22FA0042Q36047807-03903D5F-E7D1-4F0D-9899-B3D6E76395B8Q36094697-CD46BF85-102F-4B44-B1C6-C92A8C7F25B2Q36289608-119585E2-023C-4B9D-955B-93B8DE3364F5Q36394964-24E47DCE-2D28-4611-A628-491D333C7E4EQ36434358-C4FF78F5-228B-4205-88AF-A5911EC66098Q36717999-CF49B232-8CA5-4BE2-B957-BDB08699FAAFQ36810391-6CF8C1AE-6AEC-45E1-91FA-C134A0C6D7D1Q36921714-A341F1BE-0DEC-4B5A-AB49-01F731230712Q37133709-FE8EBC47-CD54-4DF5-8BD3-B55512544777Q37151909-20A3934A-2474-471F-8368-27B83C20D347Q37698645-6707D262-90A7-472A-82FC-65F613E2F756Q37861635-51041FED-577E-4BC4-B326-B11558B1C3F6Q37936020-D220D5C1-C667-481B-8B48-8F2E4376D986Q38024864-24A2DDC2-3D38-404B-9E91-C57841E9FF06Q38103175-7349AD23-4063-487E-B05E-02EE8ED7AFE8Q38114000-31A67B9D-2FFC-4355-BE7A-11C03D972185Q38151195-21D1B8D1-5C71-4AF5-BA32-4D2DB0365C39Q38161351-F8E2830D-E0FA-4460-AAFE-B7AA7FC43CBAQ38169258-379916D0-9FB5-4104-A70A-CFAED3AD446B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary bioassay of human myeloma stem cells.
@en
Primary bioassay of human myeloma stem cells.
@nl
type
label
Primary bioassay of human myeloma stem cells.
@en
Primary bioassay of human myeloma stem cells.
@nl
prefLabel
Primary bioassay of human myeloma stem cells.
@en
Primary bioassay of human myeloma stem cells.
@nl
P2860
P356
P1476
Primary bioassay of human myeloma stem cells.
@en
P2093
A Hamburger
S E Salmon
P2860
P304
P356
10.1172/JCI108839
P407
P577
1977-10-01T00:00:00Z